Invention Grant
- Patent Title: Pyrazolyl derivatives useful as anti-cancer agents
-
Application No.: US17125335Application Date: 2020-12-17
-
Publication No.: US11702409B2Publication Date: 2023-07-18
- Inventor: Simona Cotesta , Marc Gerspacher , Catherine Leblanc , Edwige Liliane Jeanne Lorthiois , Bo Liu , Rainer Machauer , Robert Mah , Christophe Mura , Pascal Rigollier , Nadine Schneider , Stefan Stutz , Andrea Vaupel , Nicolas Warin , Rainer Wilcken
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agency: Lathrop GPM LLP
- Agent Brian C. Trinque; Nicole Sassu
- Priority: WO TCN2020125425 2020.10.30
- Main IPC: C07D403/14
- IPC: C07D403/14 ; C07D401/14 ; C07D405/14 ; C07D413/14 ; C07D417/14 ; C07D471/04 ; C07D487/04
Abstract:
The present invention provides a compound of formula (I) or a stereoisomer thereof, or an atropisomer thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt of a stereoisomer thereof, or a pharmaceutically acceptable salt of an atropisomer thereof;
a method for manufacturing said compound, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition comprising said compound.
a method for manufacturing said compound, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition comprising said compound.
Public/Granted literature
- US20220363670A1 Pyrazolyl derivatives useful as anti-cancer agents Public/Granted day:2022-11-17
Information query
